Author:
Naaldijk Yahaira M.,Bittencourt Maria C.,Sack Ulrich,Ulrich Henning
Abstract
Abstract
Bipolar disorder (BD) is a severe psychiatric disorder that affects up to 15% of the worldwide population. Characterized by switches in mood between mania and depression, its etiology is still unknown and efforts have been made to elucidate the mechanisms involved in first episode, development and progression of the disorder. Microglia activation, abnormal activity of GSK-3β and reduction in neurotrophic factor expression related to neuroinflammatory processes have been indicated to be part of the disorder’s pathophysiology. Lithium, the main mood stabilizer used for the treatment and prevention of relapses, acts as an anti-inflammatory agent. Based on that, here we suggest a neuroinflammatory pathway for would be BD progression, in which microglia activation states modulated via constitutive induction of kinin-B1 receptor and reduction of kinin-B2 receptor expression and activity.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference312 articles.
1. Berberine alleviates cardiac ischemia / reperfusion injury by inhibiting excessive autophagy in cardiomyocytes;Huang;Eur J Pharmacol
2. single nucleotide polymorphism in glycogen synthase kinase - beta promoter gene influences onset of illness in patients affected by bipolar disorder;Benedetti;Neurosci Lett,2004
3. Bradykinin - induced microglial migration mediated by bradykinin receptors depends on Ca influx via reverse - mode activity of the Na Ca exchanger;Ifuku;Neurosci,2007
4. receptor ligands therapeutic perspectives;Marceau;Nat Rev Drug Discov,2004
5. Neuroprotective role of bradykinin because of the attenuation of pro - inflammatory cytokine release from activated microglia;Noda;Neurochem,2007
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献